GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » COGS-to-Revenue

Ypsomed Holding AG (CHIX:YPSNZ) COGS-to-Revenue : 0.65 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG COGS-to-Revenue?

Ypsomed Holding AG's Cost of Goods Sold for the six months ended in Mar. 2024 was CHF191.8 Mil. Its Revenue for the six months ended in Mar. 2024 was CHF293.1 Mil.

Ypsomed Holding AG's COGS to Revenue for the six months ended in Mar. 2024 was 0.65.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Ypsomed Holding AG's Gross Margin % for the six months ended in Mar. 2024 was 34.54%.


Ypsomed Holding AG COGS-to-Revenue Historical Data

The historical data trend for Ypsomed Holding AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG COGS-to-Revenue Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.77 0.76 0.72 0.66

Ypsomed Holding AG Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.73 0.70 0.66 0.65

Ypsomed Holding AG COGS-to-Revenue Calculation

Ypsomed Holding AG's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=359.404 / 548.457
=0.66

Ypsomed Holding AG's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=191.831 / 293.067
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (CHIX:YPSNz) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Ypsomed Holding AG's Gross Margin % for the six months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 191.831 / 293.067
=34.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Ypsomed Holding AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (CHIX:YPSNZ) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (CHIX:YPSNZ) Headlines

No Headlines